Injac R - Search Results

1

Effects of fullerenol C60(OH)24 nanoparticles on a single-dose doxorubicin-induced cardiotoxicity in pigs: an ultrastructural study.

Borović ML, Ičević I, Kanački Z, Žikić D, Seke M, Injac R, Djordjević A. Borović ML, et al. Among authors: injac r. Ultrastruct Pathol. 2014 Apr;38(2):150-63. doi: 10.3109/01913123.2013.822045. Epub 2013 Oct 17. Ultrastruct Pathol. 2014. PMID: 24134482

2

Cardioprotective effects of fullerenol C(60)(Oh)(24) on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm.

Injac R, Perse M, Boskovic M, Djordjevic-Milic V, Djordjevic A, Hvala A, Cerar A, Strukelj B. Injac R, et al. Technol Cancer Res Treat. 2008 Feb;7(1):15-25. doi: 10.1177/153303460800700102. Technol Cancer Res Treat. 2008. PMID: 18198920 Free article.

3

Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas.

Injac R, Perse M, Obermajer N, Djordjevic-Milic V, Prijatelj M, Djordjevic A, Cerar A, Strukelj B. Injac R, et al. Biomaterials. 2008 Aug-Sep;29(24-25):3451-60. doi: 10.1016/j.biomaterials.2008.04.048. Epub 2008 May 27. Biomaterials. 2008. PMID: 18501960

4

Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer.

Injac R, Perse M, Cerne M, Potocnik N, Radic N, Govedarica B, Djordjevic A, Cerar A, Strukelj B. Injac R, et al. Biomaterials. 2009 Feb;30(6):1184-96. doi: 10.1016/j.biomaterials.2008.10.060. Epub 2008 Dec 1. Biomaterials. 2009. PMID: 19046599

5

Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress.

Injac R, Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, Strukelj B. Injac R, et al. Pharmacol Rep. 2008 Sep-Oct;60(5):742-9. Pharmacol Rep. 2008. PMID: 19066422 Free article.

6

Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C60(OH)24 through inhibition of oxidative stress.

Injac R, Radic N, Govedarica B, Perse M, Cerar A, Djordjevic A, Strukelj B. Injac R, et al. Pharmacol Rep. 2009 Mar-Apr;61(2):335-42. doi: 10.1016/s1734-1140(09)70041-6. Pharmacol Rep. 2009. PMID: 19443948 Free article.

7

Activity of antioxidative enzymes in erythrocytes after a single dose administration of doxorubicin in rats pretreated with fullerenol C(60)(OH)(24).

Milic VD, Stankov K, Injac R, Djordjevic A, Srdjenovic B, Govedarica B, Radic N, Simic VD, Strukelj B. Milic VD, et al. Among authors: injac r. Toxicol Mech Methods. 2009 Jan;19(1):24-8. doi: 10.1080/01612840802203098. Toxicol Mech Methods. 2009. PMID: 19778229

8

Fullerenol nanoparticles: toxicity and antioxidant activity.

Injac R, Prijatelj M, Strukelj B. Injac R, et al. Methods Mol Biol. 2013;1028:75-100. doi: 10.1007/978-1-62703-475-3_5. Methods Mol Biol. 2013. PMID: 23740114 Review.

9

Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.

Potočnik N, Perše M, Cerar A, Injac R, Finderle Ž. Potočnik N, et al. Among authors: injac r. PLoS One. 2017 Jul 20;12(7):e0181632. doi: 10.1371/journal.pone.0181632. eCollection 2017. PLoS One. 2017. PMID: 28727839 Free PMC article.

10

Analysis of doxorubicin and fullerenol in rat serum by micellar electrokinetic capillary chromatography.

Injac R, Sertić M, Glavač NK. Injac R, et al. Acta Pharm. 2024 Sep 14;74(3):495-509. doi: 10.2478/acph-2024-0026. Print 2024 Sep 1. Acta Pharm. 2024. PMID: 39279531 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters